Want to see IN:MEDPLUS full AI Analyst Report?
MEDPLUS Stock Chart & Stats
₹808.80
₹1.40(0.17%)
At close: 4:00 PM EST
₹808.80
₹1.40(0.17%)
Day’s Range― - ―
52-Week Range₹620.00 - ₹1,020.35
Previous CloseN/A
Volume104.47K
Average Volume (3M)19.04K
Market Cap
₹75.06B
Enterprise Value₹108.84B
Total Cash (Recent Filing)₹6.13B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)35.6
Beta0.59
Next Earnings
Oct 27, 2026EPS Estimate
4.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)17.55
Shares Outstanding120,137,060
10 Day Avg. Volume18,010
30 Day Avg. Volume19,042
Financial Highlights & Ratios
PEG Ratio0.99
Price to Book (P/B)5.10
Price to Sales (P/S)1.46
P/FCF Ratio24.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)17.28
Revenue Forecast (FY)₹80.52B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue ExpansionConsistent revenue scaling across 2021–2026 indicates a durable expansion trajectory for the pharmacy and health-services platform. Continued growth can broaden the store and digital customer base, improve procurement scale, and create operating leverage if the company sustains disciplined execution.
Improved Cash GenerationThe improvement to solidly positive operating and free cash flow in 2025–2026 strengthens the company’s ability to fund store expansion, digital investment, and other operating needs internally. This reduces reliance on external financing and provides greater flexibility over the next several quarters.
Growing Asset And Equity BaseSteady growth in assets and equity shows that the balance sheet has expanded alongside the business rather than relying solely on debt. Although leverage has increased, the current capital structure remains reasonably supported by equity, helping preserve capacity for continued network development.
Bears Say
Thin And Volatile ProfitabilityPersistently thin net margins leave limited room to absorb pricing pressure, cost increases, or weaker product mix. The sharp 2026 gross-margin decline also indicates that profitability is not yet consistently durable, so revenue growth may translate into only modest earnings improvement.
Increasing Leverage For A Thin-margin BusinessRising leverage increases the financial sensitivity of a business whose net margins are already low. Greater debt reliance can constrain future investment choices and make interest, refinancing, or operating pressures more consequential if profitability does not strengthen sustainably.
Inconsistent Cash ConversionThe uneven history of cash conversion suggests that reported earnings do not always translate fully into available cash. At roughly 0.77 times net income in 2026, free cash flow remains subject to working-capital or reinvestment demands, which can limit funding flexibility.
MedPlus Health Services Ltd. News
MEDPLUS FAQ
What was MedPlus Health Services Ltd.’s price range in the past 12 months?
MedPlus Health Services Ltd. lowest stock price was ₹620.00 and its highest was ₹1020.35 in the past 12 months.
What is MedPlus Health Services Ltd.’s market cap?
MedPlus Health Services Ltd.’s market cap is ₹75.06B.
When is MedPlus Health Services Ltd.’s upcoming earnings report date?
MedPlus Health Services Ltd.’s upcoming earnings report date is Oct 27, 2026 which is in 15 days.
How were MedPlus Health Services Ltd.’s earnings last quarter?
MedPlus Health Services Ltd. released its earnings results on Jul 21, 2026. The company reported ₹2.8 earnings per share for the quarter, beating the consensus estimate of ₹1.95 by ₹0.85.
Is MedPlus Health Services Ltd. overvalued?
According to Wall Street analysts MedPlus Health Services Ltd.’s price is currently Overvalued.
Does MedPlus Health Services Ltd. pay dividends?
MedPlus Health Services Ltd. does not currently pay dividends.
What is MedPlus Health Services Ltd.’s EPS estimate?
MedPlus Health Services Ltd.’s EPS estimate is 4.6.
How many shares outstanding does MedPlus Health Services Ltd. have?
MedPlus Health Services Ltd. has 120,137,060 shares outstanding.
What happened to MedPlus Health Services Ltd.’s price movement after its last earnings report?
MedPlus Health Services Ltd. reported an EPS of ₹2.8 in its last earnings report, beating expectations of ₹1.95. Following the earnings report the stock price went down -0.693%.
Which hedge fund is a major shareholder of MedPlus Health Services Ltd.?
Currently, no hedge funds are holding shares in IN:MEDPLUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MedPlus Health Services Ltd.
MedPlus Health Services Limited operates primarily as an Indian retailer of pharmaceutical products and diverse general merchandise. Its extensive product catalog includes vital health and wellness items such as prescription medications, vitamins, medical equipment, and diagnostic kits, alongside everyday essentials like toiletries, baby care products, cleaning supplies, and sanitizers. Beyond its retail footprint, the company also offers wholesale cash-and-carry services, comprehensive pathological laboratory testing, and contract manufacturing for its own-brand pharmaceutical goods. By March 31, 2021, MedPlus had established a substantial presence with 1,659 brick-and-mortar stores situated in the Indian states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, complemented by its online store. This Hyderabad-based company was incorporated in 2006.
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Sastasundar Ventures Limited
―
Thyrocare Technologies Ltd
―